Clovis Oncology Inc (NASDAQ:CLVS)

54.15
Delayed Data
As of Feb 16
 -0.43 / -0.79%
Today’s Change
45.42
Today|||52-Week Range
99.45
-20.37%
Year-to-Date
No recent news for Clovis Oncology Inc.

Today’s Trading

Previous close54.58
Today’s open54.41
Day’s range54.09 - 56.36
Volume675,404
Average volume (3 months)1,234,587
Market cap$2.7B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+15.51%
Earnings growth (next 5 years)+56.05%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.27-0.56%
OPKOPKO Health Inc-0.11-2.78%
PBYIPuma Biotechnology I...-1.05-1.54%
MNKMallinckrodt Plc+0.06+0.36%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Principal Financial Officer &
SVP-Finance
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts